- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02785016
Surgical Management for Suburethral Slings
March 6, 2024 updated by: Prof. Dr. Volker Viereck, Cantonal Hospital, Frauenfeld
Prospective, Non-Randomized, Observational Trial of the Surgical Management for Suburethral Slings in Women With Stress Urinary Incontinence
This is a prospective, non-randomized, observational, single center study in which subjects that have surgically-correctable Stress Urinary Incontinence undergo a suburethral sling operative procedure.
Study Overview
Status
Recruiting
Conditions
Detailed Description
The study will collect preoperative urologic testing, medical history, and subject quality of life patient questionnaires. Intraoperative procedural data will be collected.
Postoperative complications, urologic, testing, and subject questionnaires will be collected at intervals. The anatomic position of the device will be characterize by introital ultrasound testing.
Study Type
Observational
Enrollment (Estimated)
100
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Volker Viereck, Physican
- Phone Number: ++41 52 723 70 50
- Email: volker.viereck@stgag.ch
Study Contact Backup
- Name: Oliver Rautenberg, Physican
- Phone Number: ++41 52 723 77 45
- Email: oliver.rautenberg@stgag.ch
Study Locations
-
-
Thurgau
-
Frauenfeld, Thurgau, Switzerland, 8501
- Recruiting
- Blasenzentrum, Cantonal Hospital
-
Contact:
- Volker VV Viereck, Physican
- Phone Number: ++41 52 723 70 50
- Email: volker.viereck@stgag.ch
-
Contact:
- Oliver OR Rautenberg, Physican
- Phone Number: ++41 52 723 75 45
- Email: oliver.rautenberg@stgag.ch
-
Principal Investigator:
- Volker VV Viereck, Physican
-
Sub-Investigator:
- Oliver OR Rautenberg, Physican
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Probability Sample
Study Population
Subjects that have surgically-correctable Stress Urinary Incontinence and undergo a suburethral sling operative procedure.
Description
Inclusion Criteria:
- Patient has objective demonstrable signs of stress urinary incontinence (SUI), including patients with intrinsic sphincter deficiency (ISD). Objective testing includes: standing stress test, urodynamics evaluation, or pad test.
- Patient is age 18 or older.
- Patient agrees to participate in the study, including completion of all study-related procedures and evaluations, and documents this agreement by signing the IRB/EC-approved informed consent.
- Patient is able to fill in all questionnaires (on judgement of investigator)
Exclusion Criteria:
- Patient has an associated or suspected neurological disease.
- Patient has an active lesion or present injury to perineum or urethra.
- Patient has a urethral obstruction.
- Patient has significant pelvic organ prolapse (Grade III/IV) requiring surgical treatment.
- The subject has current urinary tract infection.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
---|
Stress Urinary Incontinence
Females with stress urinary incontinence, who undergo a tension free surgical sling procedure.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Cure/improvement rate
Time Frame: 3 months
|
Patients are classified as cured if the postoperative cough test (see Outcome 4 below) is negative and the degree of subjective suffering (see Outcome 2 below) improves to over 90% (VAS score of 0 or 1).
Criteria for improvement are involuntary loss of only a few drops of urine during straining and an improvement of the degree of suffering to over 75% (VAS score of 2 or 3).
All other patients are classified as therapeutic failures (even if they show marked improvement of one of the parameters compared with their preoperative status).
|
3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Subjective symptom assessment by visual analogue scale
Time Frame: 3 and 6 months
|
Scale: 0-10 (0-no suffering, 10-severe suffering)
|
3 and 6 months
|
Post-Operative Pain Assessment
Time Frame: 1 day
|
Scale: 0-10 (0-no pain, 10-severe pain)
|
1 day
|
Standing Cough Stress Test
Time Frame: baseline, 3 and 6 months
|
3 categories: negative/severe, if flow of urine is observed.
negative/mild, if the loss of only a few drops is observed.
positive, if no urine loss occurs.
|
baseline, 3 and 6 months
|
King Health Questionnaire
Time Frame: pre-operation, 3 and 6 months
|
pre-operation, 3 and 6 months
|
|
International Consultation on Incontinence Questionnaire
Time Frame: pre-operation, 3 and 6 months
|
pre-operation, 3 and 6 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Volker Viereck, Physican, Cantonal Hospital, Frauenfeld
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
May 1, 2013
Primary Completion (Estimated)
December 1, 2024
Study Completion (Estimated)
July 1, 2025
Study Registration Dates
First Submitted
May 19, 2016
First Submitted That Met QC Criteria
May 26, 2016
First Posted (Estimated)
May 27, 2016
Study Record Updates
Last Update Posted (Actual)
March 7, 2024
Last Update Submitted That Met QC Criteria
March 6, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
- Behavioral Symptoms
- Mental Disorders
- Urologic Diseases
- Lower Urinary Tract Symptoms
- Urological Manifestations
- Urination Disorders
- Elimination Disorders
- Female Urogenital Diseases
- Female Urogenital Diseases and Pregnancy Complications
- Urogenital Diseases
- Male Urogenital Diseases
- Urinary Incontinence
- Enuresis
- Urinary Incontinence, Stress
Other Study ID Numbers
- TVT 3D
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
UNDECIDED
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Stress Urinary Incontinence
-
University of New MexicoRecruitingUrinary Incontinence | Urge Incontinence | Stress Incontinence, FemaleUnited States
-
Juna d.o.o.CompletedFemale Stress Urinary Incontinence | Mixed Incontinence, Urge and Stress
-
University of California, San FranciscoNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Stanford...CompletedUrinary Incontinence, Stress | Urge Incontinence | Urinary Stress Incontinence | Stress Incontinence, Urinary | Stress Incontinence | Stress Incontinence, Female | Urgency UrinaryUnited States
-
Far Eastern Memorial HospitalRecruitingWomen With Stress Urinary IncontinenceTaiwan
-
Université de SherbrookeRecruitingUrinary Incontinence | Urinary Stress Incontinence | Post-Prostatectomy Incontinence | Stress Incontinence, MaleCanada
-
Hadassah Medical OrganizationCompletedUrinary Stress Incontinence (SI)Israel
-
University Magna GraeciaUnknownStress Urinary IncontinenceItaly
-
University of California, IrvineWithdrawnStress Urinary IncontinenceUnited States
-
Eli Lilly and CompanyBoehringer IngelheimCompleted
-
Eli Lilly and CompanyBoehringer IngelheimCompletedUrinary Stress IncontinenceUnited States